These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 19234121)
21. LL-37 inhibits LPS-induced inflammation and stimulates the osteogenic differentiation of BMSCs via P2X7 receptor and MAPK signaling pathway. Yu X; Quan J; Long W; Chen H; Wang R; Guo J; Lin X; Mai S Exp Cell Res; 2018 Nov; 372(2):178-187. PubMed ID: 30287143 [TBL] [Abstract][Full Text] [Related]
22. Treatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancer. Chuang CM; Monie A; Wu A; Mao CP; Hung CF Hum Gene Ther; 2009 Apr; 20(4):303-13. PubMed ID: 19272013 [TBL] [Abstract][Full Text] [Related]
23. Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment. Sainz B; Alcala S; Garcia E; Sanchez-Ripoll Y; Azevedo MM; Cioffi M; Tatari M; Miranda-Lorenzo I; Hidalgo M; Gomez-Lopez G; Cañamero M; Erkan M; Kleeff J; García-Silva S; Sancho P; Hermann PC; Heeschen C Gut; 2015 Dec; 64(12):1921-35. PubMed ID: 25841238 [TBL] [Abstract][Full Text] [Related]
24. IL-33 synergistically promotes the proliferation of lung cancer cells in vitro by inducing antibacterial peptide LL-37 and proinflammatory cytokines in macrophages. Jiang Y; Liao H; Zhang X; Cao S; Hu X; Yang Z; Fang Y; Wang H Immunobiology; 2020 Nov; 225(6):152025. PubMed ID: 33190003 [TBL] [Abstract][Full Text] [Related]
25. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway. Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089 [TBL] [Abstract][Full Text] [Related]
26. Pancreatic cancer growth promoted by bone marrow mesenchymal stromal cell-derived IL-6 is reversed predominantly by IL-6 blockade. Antoon R; Wang XH; Saleh AH; Warrington J; Hedley DW; Keating A Cytotherapy; 2022 Jul; 24(7):699-710. PubMed ID: 35473998 [TBL] [Abstract][Full Text] [Related]
27. [Mechanisms of antimicrobial peptide LL-37 in macrophage-promoted ovarian cancer cell proliferation]. Li D; Wang X; Dai Y; Yang F; Wan HY Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):660-5. PubMed ID: 24332052 [TBL] [Abstract][Full Text] [Related]
28. [Effect of antibacterial peptide hCAP18/LL-37 on ovarian cancer microenvironment and the regulatory mechanism of its expression]. Lu Q; Quan W; Wu J; Zhang X; Ma W; Pang L; Li D Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):725-30. PubMed ID: 26813589 [TBL] [Abstract][Full Text] [Related]
29. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Hung SC; Pochampally RR; Chen SC; Hsu SC; Prockop DJ Stem Cells; 2007 Sep; 25(9):2363-70. PubMed ID: 17540857 [TBL] [Abstract][Full Text] [Related]
30. Role of VEGF-A in angiogenesis promoted by umbilical cord-derived mesenchymal stromal/stem cells: in vitro study. Arutyunyan I; Fatkhudinov T; Kananykhina E; Usman N; Elchaninov A; Makarov A; Bolshakova G; Goldshtein D; Sukhikh G Stem Cell Res Ther; 2016 Mar; 7():46. PubMed ID: 27001300 [TBL] [Abstract][Full Text] [Related]
31. The bone marrow-expressed antimicrobial cationic peptide LL-37 enhances the responsiveness of hematopoietic stem progenitor cells to an SDF-1 gradient and accelerates their engraftment after transplantation. Wu W; Kim CH; Liu R; Kucia M; Marlicz W; Greco N; Ratajczak J; Laughlin MJ; Ratajczak MZ Leukemia; 2012 Apr; 26(4):736-45. PubMed ID: 21931324 [TBL] [Abstract][Full Text] [Related]
32. Tumor stroma engraftment of gene-modified mesenchymal stem cells as anti-tumor therapy against ovarian cancer. Dembinski JL; Wilson SM; Spaeth EL; Studeny M; Zompetta C; Samudio I; Roby K; Andreeff M; Marini FC Cytotherapy; 2013 Jan; 15(1):20-32. PubMed ID: 23260083 [TBL] [Abstract][Full Text] [Related]
33. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer. Shinagawa K; Kitadai Y; Tanaka M; Sumida T; Onoyama M; Ohnishi M; Ohara E; Higashi Y; Tanaka S; Yasui W; Chayama K Int J Cancer; 2013 Feb; 132(4):813-23. PubMed ID: 22821812 [TBL] [Abstract][Full Text] [Related]
34. Paracrine effect of inflammatory cytokine-activated bone marrow mesenchymal stem cells and its role in osteoblast function. Li C; Li G; Liu M; Zhou T; Zhou H J Biosci Bioeng; 2016 Feb; 121(2):213-9. PubMed ID: 26315505 [TBL] [Abstract][Full Text] [Related]
35. Priming with ligands secreted by human stromal progenitor cells promotes grafts of cardiac stem/progenitor cells after myocardial infarction. Iso Y; Rao KS; Poole CN; Zaman AK; Curril I; Sobel BE; Kajstura J; Anversa P; Spees JL Stem Cells; 2014 Mar; 32(3):674-83. PubMed ID: 24022988 [TBL] [Abstract][Full Text] [Related]
36. Small Extracellular Vesicles Released from Ovarian Cancer Spheroids in Response to Cisplatin Promote the Pro-Tumorigenic Activity of Mesenchymal Stem Cells. Vera N; Acuña-Gallardo S; Grünenwald F; Caceres-Verschae A; Realini O; Acuña R; Lladser A; Illanes SE; Varas-Godoy M Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600881 [TBL] [Abstract][Full Text] [Related]
37. Development of a surrogate potency assay to determine the angiogenic activity of Stempeucel®, a pooled, ex-vivo expanded, allogeneic human bone marrow mesenchymal stromal cell product. Thej C; Ramadasse B; Walvekar A; Majumdar AS; Balasubramanian S Stem Cell Res Ther; 2017 Feb; 8(1):47. PubMed ID: 28245882 [TBL] [Abstract][Full Text] [Related]